Quarantine requirements for the importation of black rhinoceros from Zimbabwe into Australia

SUMMARY The proposal by the Zoological Parks Board of New South Wales to import 10 southern black rhinoceros (Diceros bicornis) from Zimbabwe as part of an international project for conservation of the species presented the Australian Quarantine and Inspection Service (AQIS) with a unique challenge. This importation is, at least in the modern era, the first importation of live herbivores from the African continent. Many of the serious animal diseases in the world are endemic in parts of Africa. Knowledge of which of these diseases infect wild species and may be transmitted from the wild species to domesticated species, is limited. This paper describes the strategies adopted by AQIS to facilitate the importation of rhinoceros while maintaining protection of Australian consumers, rural industries, domestic livestock and fauna against the entry and spread of unwanted pests and diseases.     

MAGNETIC RESONANCE IMAGING FINDINGS OF PRESUMED CEREBELLAR CEREBROVASCULAR ACCIDENT IN TWELVE DOGS

The magnetic resonance imaging (MRI) findings of presumed cerebrovascular accident in 12 dogs are described. Fourteen lesions were seen, commonly (11 of 14) within the gray matter of the cerebellar hemispheres or vermis. Thirteen lesions were hyperintense on T2-weighted images (in 11 dogs) and one was hypointense. Eleven of 14 lesions were within the region supplied by the rostral cerebellar artery or one of its main branches and there was no, or minimal, mass effect. Contrast enhancement was only seen in six lesions and was mild in all. Gradient-echo images provided additional information in two dogs. The appearance of infarction in dogs with diffusion-weighted images (DWI) is similar to that in humans, and provided supportive evidence for the diagnosis of infarction in five dogs. The use of gradient-echo and DWI is recommended for the evaluation of suspected cerebrovascular accidents in dogs. Six of the 12 affected animals were spaniels or spaniel crosses, suggesting a possible breed predisposition.     

Variability in responses of US-8 and US-11 genotypes of potato and tomato isolates ofPhytophthora infestans to commercial fungicidesin vitro

Isolates ofPhytophthora infestans collected in Canada from potato and tomato plants from 1994 to 1998 were tested for their responsein vitro to equal active ingredient concentrations (1, 2.5, and 5 μg a.i/mL) of six commercial fungicides: Acrobat MZ (dimethomorph and mancozeb), Ridomil Gold (metalaxyl-m), Dithane (mancozeb), Curzate (cymoxanil), Bravo (chlorothalonil), and Tattoo C (propamocarb and chlorothalonil). Relative mycelial growth of isolates estimated on fungicideamended vs fungicide-free media was compared among isolates of the US-8 and US-11 genotypes from the two host plants. The effects of these fungicides on spore germination of isolates from the two genotypes were also estimated. Mycelial growth of US-8 and US-11 isolates was most affected by Bravo and Tattoo C, followed by Acrobat, and then Curzate and Dithane. Ridomil Gold was not effective in inhibitingin vitro growth of US-11 isolates at the concentrations tested. Variations in sensitivity to different fungicides among isolates of the same genotype collected in different years were observed. For example, based on 2.5 and 5 μg a.i./mL, potato/US-11 isolates collected from 1995 to 1997 showed increased sensitivity to Curzate and Ridomil Gold, while decreased sensitivity was recorded with Dithane. For US-8 isolates, responses to the fungicides varied according to fungicide and year. Variations were generally not significant for Acrobat, Curzate, Bravo, and Tattoo C over time. Conversely, potato/US-8 isolates from 1995 and 1998 were less sensitive to Dithane and Ridomil Gold than those from 1994, 1996, and 1997.     

Assessment of mating types and resistance to metalaxyl of Canadian populations ofPhytophthora infestans in 1997

The distribution of A1 and A2 mating types, and of metalaxyl-sensitive (MS), metalaxyl-intermediate (MI), and metalaxyl-resistant (MR) strains ofPhytophthora infestans, the causal pathogen of late blight, were determined in Canada in 1997. Potato plants or tubers and tomato plants or fruits, suspected to have late blight infection, were received from seven Canadian provinces in 1997, and were assessed for the presence ofP. infestans. Among 220 samples suspected to have late blight,P. infestans was recovered from 132 samples (60%) received from British Columbia (BC), Manitoba, New Brunswick, Prince Edward Island, and Quebec. From the 132 samples, 364 isolates were obtained and tested for their mating type and response to metalaxyl. Populations ofP. infestans within Canadian provinces were homogeneous for mating types, except within BC, where populations comprised both A1 and A2 mating types both within fields and sometimes within samples. The A2 mating type was found in all provinces where late blight was present. The A1 mating type was found only in Manitoba (1 isolate) and in BC (38 isolates). Unlike the old A1 isolates, those found in BC in 1997 were highly resistant to metalaxyl. These A1 isolates are even more resistant than A2 isolates. Based on assays with 10 ug.ml^?1 of metalaxyl, 14% of all tested isolates were MS, 69.8% were MI and 16.2% were MR. In addition, all provinces contained MS, MI, and MR isolates. No specific mating type or metalaxyl sensitivity level were specific to tomato or potato.     

改进培养方法提高组培快繁技术的初探

通过简化培养基成分，去除有机物、琼脂等，可降低试管苗成本；采用自然光替代日光灯，并结合黑暗培养，可减少设备投入．有利于工厂化育苗生产。     

水生植被对洪泽湖湖滨湿地水环境净化效果及影响因素分析(英文)

[目的]分析研究洪泽湖湖滨地区植物群落对湿地水环境的净化效果,为该区生态修复提供参考依据。[方法]以洪泽湖湿地国家级自然保护区典型湖滨带为研究对象,通过对该区的水草区和无草区环境特征进行野外调查,并结合室内试验,测定湖泊湿地水体的营养盐(N和P)、化学需氧量(COD)及透明度(SD)含量的变化,定量分析水生植被在生长过程中对湖泊湿地生态系统中水环境的净化效果,并对其可能存在的影响因素进行探讨。[结果]水生植被对洪泽湖湿地水环境中TN、TP、COD、Chla的去除作用及对SD含量变化有较明显的影响。水生植物之间的竞争可以抑制藻类的生长,减轻水体的富营养化情况。[结论]该试验为研究洪泽湖湖滨带生态修复及增强其自净能力提供理论依据。     

2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs

This report represents a scientific and working clinical consensus statement on seizure management in dogs based on current literature and clinical expertise. The goal was to establish guidelines for a predetermined, concise, and logical sequential approach to chronic seizure management starting with seizure identification and diagnosis (not included in this report), reviewing decision‐making, treatment strategies, focusing on issues related to chronic antiepileptic drug treatment response and monitoring, and guidelines to enhance patient response and quality of life. Ultimately, we hope to provide a foundation for ongoing and future clinical epilepsy research in veterinary medicine.     

Retrospective assessment of tolerability and efficacy of zoledronate in the palliative treatment of cancer-bearing dogs

Zoledronate is a bisphosphonate frequently used for the treatment of hypercalcaemia of malignancy and tumour-associated bone pain in dogs, however, there is a paucity of information regarding its use in veterinary medicine. The aim of this retrospective study was to report the tolerability of zoledronate in the palliative treatment of cancer-bearing dogs and secondarily to to assess the efficacy of zoledronate for the treatment of hypercalcaemia of malignancy. Thirty-seven dogs (22 with tumour-associated bone pain and 15 with hypercalcaemia of malignancy) that received 114 zoledronate infusions were included. Tolerability was assessed by the absence of post-zoledronate hypocalcaemia or other adverse events as defined by Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events criteria. Efficacy was assessed by comparison of available ionized calcium levels before and after zoledronate administration in hypercalcaemic dogs. In 79% of zoledronate infusions, no adverse events were reported. The majority of adverse events which occurred in the other 21% of infusions could be attributed to concurrent chemotherapy or the underlying neoplastic disease. There was a small but significant increase in creatinine following treatment with zoledronate, however, none of the dogs developed clinically significant renal disease. In eight hypercalcaemic dogs with available ionized calcium following zoledronate administration, ionized calcium decreased rapidly within 7 days following treatment with zoledronate. Zoledronate is well-tolerated with few recorded adverse events, however, monitoring of serum creatinine is advised. Zoledronate seems to be effective in the treatment of hypercalcaemia of malignancy.